Literature DB >> 3276681

Substrate specificity of eukaryotic signal peptidase. Site-saturation mutagenesis at position -1 regulates cleavage between multiple sites in human pre (delta pro) apolipoprotein A-II.

R J Folz1, S F Nothwehr, J I Gordon.   

Abstract

We have previously described a novel mutant of human preproapolipoprotein A-II (pre(delta pro)apoA-II) in which the wild-type 18-amino acid-long signal sequence (Gly18 decreases) was functionally redefined to 20 amino acids in length (Ala 20 decreases). We have used this mutant as a model preprotein to probe the substrate specificity of eukaryotic signal peptidase. Site-saturation mutagenesis was performed resulting in the substitution of 13 different amino acids (acidic, basic, aromatic, hydrophobic, and small-neutral) for Ala20 (or position -1). The effects of these substitutions were assessed using an in vitro transcription/translation/microsomal membrane processing system. NH2-terminal sequence analysis of the 13 mutant proteins demonstrated that amino acids which occupy position -1 in a signal peptide are critical in establishing a good context for signal peptidase cleavage and that two or more potential sites of cleavage may compete for recognition by signal peptidase.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3276681

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Replication of human immunodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acid.

Authors:  M L Bryant; R O Heuckeroth; J T Kimata; L Ratner; J I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

2.  In vitro processing of tomato proteinase inhibitor I by barley microsomal membranes: a system for analysis of cotranslational processing of plant endomembrane proteins.

Authors:  K W Osteryoung; L Sticher; R L Jones; A B Bennett
Journal:  Plant Physiol       Date:  1992-06       Impact factor: 8.340

Review 3.  Proteolysis in protein import and export: signal peptide processing in eu- and prokaryotes.

Authors:  M Müller
Journal:  Experientia       Date:  1992-02-15

4.  Albumin Redhill (-1 Arg, 320 Ala----Thr): a glycoprotein variant of human serum albumin whose precursor has an aberrant signal peptidase cleavage site.

Authors:  S O Brennan; T Myles; R J Peach; D Donaldson; P M George
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

Review 5.  The signal peptide.

Authors:  G von Heijne
Journal:  J Membr Biol       Date:  1990-05       Impact factor: 1.843

Review 6.  The chemistry and enzymology of the type I signal peptidases.

Authors:  R E Dalbey; M O Lively; S Bron; J M van Dijl
Journal:  Protein Sci       Date:  1997-06       Impact factor: 6.725

7.  Downregulation of otospiralin, a novel inner ear protein, causes hair cell degeneration and deafness.

Authors:  Benjamin Delprat; Ana Boulanger; Jing Wang; Vicky Beaudoin; Matthieu J Guitton; Stephanie Ventéo; Claude J Dechesne; Rémy Pujol; Mireille Lavigne-Rebillard; Jean-Luc Puel; Christian P Hamel
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

8.  Identification and characterization of two mature isoforms of retinoschisin in murine retina.

Authors:  Camasamudram Vijayasarathy; Mary Ann Gawinowicz; Yong Zeng; Yuichiro Takada; Ronald A Bush; Paul A Sieving
Journal:  Biochem Biophys Res Commun       Date:  2006-08-10       Impact factor: 3.575

9.  Possible involvement of inefficient cleavage of preprovasopressin by signal peptidase as a cause for familial central diabetes insipidus.

Authors:  M Ito; Y Oiso; T Murase; K Kondo; H Saito; T Chinzei; M Racchi; M O Lively
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

10.  A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity.

Authors:  D Lindemann; T Pietschmann; M Picard-Maureau; A Berg; M Heinkelein; J Thurow; P Knaus; H Zentgraf; A Rethwilm
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.